Articles

A recent analysis revealed that patients with cancer who scored highly on depression and anxiety scales were more likely to suffer from symptoms of chemotherapy-induced nausea. 

Certain Neuropsychological Factors May Predict Occurrence of Chemotherapy-Induced Nausea

Based on results from the phase 2 GARNET trial, dostarlimab may be used to treat recurrent or advanced endometrial cancer progressing on or after treatment with a platinum-containing chemotherapy that is mismatch repair deficient.

PD-1 Inhibitor Dostarlimab Earns Accelerated Approval in Mismatch Repair Deficient Endometrial Cancer

According to the research, there are important components and factors missing from the scale commonly used to measure a clinician’s quality of life.

Nurse Quality of Life Important Component for Improved Patient Outcomes

Experts discusses the treatment of patients with HER2-positive breast cancer in a virtual CancerNetwork® Around the Practice presentation,“Relapsed/Refractory HER2+ Metastatic Breast Cancer,” held January 21, 2021, and moderated by Adam M. Brufsky, MD, PhD.

Around the Practice: Relapsed/Refractory HER2+ Metastatic Breast Cancer

Scott T. Tagawa, MD, considers data for the novel PSMA-targeted radiopharmaceutical 177Lu-PSMA-617.

PSMA-Targeted 177Lu-PSMA-617 Heads for Regulatory Approval in mCRPC

Radowan A. Elnair, MD, and Sarah A. Holstein, MD, PhD, review literature regarding progress in the management of the transplant-ineligible multiple myeloma in an article published in the journal ONCOLOGY®.

Treatment Considerations for Transplant-Ineligible Multiple Myeloma

The 2 pilot multidisciplinary care teams reported positive feedback with the collaboration, explaining that the meetings were valuable to the quality care of their patients.

Multidisciplinary Team Developed to Promote Communication and Collaboration Among Radiation Oncology Care Facility

Adverse effects management for tepotinib in patients with non–small cell lung cancer by nurses may offer the potential to increase the time on the treatment and lead to improved outcomes.

Nurse-Specific Recommendations for Adverse Effects of Tepotinib in NSCLC

A thought-provoking installment of Clinical Quandaries is presented by Alejandro Gabutti, MD; and Tommaso Cascella, MD, of a 36-year-old patient with hepatitis C virus-related cirrhosis and a subsequent diagnosis of hepatocellular carcinoma.

How to Radiologically Assess and Follow Response After Treatment of Hepatocellular Carcinoma 

Treatment care changed in the face of the COVID-19 pandemic as necessary virtual visits are proving to be more comfortable and safer for many Veteran patients and survivors of cancer. 

All News